Compounds > hydroxyproline
Page last updated: 2024-08-17

hydroxyproline and medroxyprogesterone acetate

hydroxyproline has been researched along with medroxyprogesterone acetate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grant, B; Marcus, R; Minkoff, JR; Young, G1
Lobo, RA; McCormick, W; Roy, S; Singer, F1
Silfvast, A; Simberg, N; Tiitinen, A; Viinikka, L; Ylikorkala, O1
Bigler, JM; Burckhardt, P; Landry, M; Pache, T; Renteria, S; Thiébaud, D; Welti, HJ1
Bhagat, CI; Criddle, RA; Dhaliwal, SS; Drury, PJ; Faulkner, DL; Gutteridge, DH; Holzherr, ML; Jamrozik, K; Kent, GN; Price, RI; Prince, RL; Retallack, RW; Stewart, GO; Stuckey, BG; Tran, L; Will, RK1

Trials

3 trial(s) available for hydroxyproline and medroxyprogesterone acetate

ArticleYear
High bone density in hyperandrogenic women: effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement.
    The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:2

    Topics: Adult; Alkaline Phosphatase; Bone and Bones; Bone Density; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Goserelin; Hirsutism; Humans; Hydroxyproline; Hyperandrogenism; Medroxyprogesterone Acetate; Testosterone

1996
A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone.
    Climacteric : the journal of the International Menopause Society, 1998, Volume: 1, Issue:3

    Topics: Absorptiometry, Photon; Alkaline Phosphatase; Animals; Bone Density; Calcium; Creatinine; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Femur; Horses; Humans; Hydroxyproline; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Lumbar Vertebrae; Medroxyprogesterone Acetate; Norpregnenes; Osteocalcin; Osteoporosis, Postmenopausal

1998
A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip density.
    Calcified tissue international, 2003, Volume: 73, Issue:1

    Topics: Absorptiometry, Photon; Aged; Biomarkers; Bone Density; Calcitriol; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Hip Joint; Humans; Hydroxyproline; Medroxyprogesterone Acetate; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Quality of Life; Severity of Illness Index; Single-Blind Method; Spinal Fractures; Treatment Outcome

2003

Other Studies

2 other study(ies) available for hydroxyproline and medroxyprogesterone acetate

ArticleYear
Interactions of medroxyprogesterone acetate with estrogen on the calcium-parathyroid axis in post-menopausal women.
    Maturitas, 1986, Volume: 8, Issue:1

    Topics: Adult; Aged; Calcium; Drug Therapy, Combination; Estrogens; Female; Humans; Hydroxyproline; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Parathyroid Hormone

1986
Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
    Obstetrics and gynecology, 1984, Volume: 63, Issue:1

    Topics: Adult; Calcium; Creatinine; Delayed-Action Preparations; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Humans; Hydroxyproline; Immunosuppressive Agents; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Random Allocation

1984